SRPTSarepta Therapeutics, Inc.

$2B

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$155M+2751.6% YoY

Gross Profit

$147M95.2% margin

Operating Income

-$172M-111.0% margin

Net Income

-$51M-32.8% margin

EPS (Diluted)

$-0.86

Cash Flow

Operating Cash Flow

-$232M

Free Cash Flow

-$253M

Stock-Based Comp.

$30M

Balance Sheet

Total Assets

$1.3B

Total Liabilities

$519M

Stockholders' Equity

$789M

Cash & Equivalents

$600M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$155M	$5M	+2751.6%
Gross Profit	$147M	$5M	+2682.7%
Operating Income	-$172M	-$267M	+35.7%
Net Income	-$51M	-$267M	+81.0%

SRPT FY 2017 Earnings — Sarepta Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena